NCT07398144

Brief Summary

The goal of this prospective interventional study is to compare the effectiveness of laparoscopic Burch colposuspension versus trans obturator tape in the treatment of stress urinary incontinence in adult females. The success rate will be compared between the two proceudres at 1, 3 and 6 months post operatively. Operative times, hospital stay and perioperative complications will be evaluated in both arms Participants will be asked to:

  • complete the ICIQ-UI-SF questionnaire pre operatively and at 1, 3 and 6 months post operatively
  • undergo a pelvic examination pre operatively
  • undergo cough stress test pre operatively and at 1, 3 and 6 months post operatively
  • undergo a pressure flow study test pre operatively
  • undergo pelviabdominal ultrasound with post void residual urine measurement pre operatively and at 1, 3 and 6 months post operatively
  • undergo uroflowmetry at 1 month post operatively

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

8 months

First QC Date

February 2, 2026

Last Update Submit

February 9, 2026

Conditions

Keywords

laparoscopic Burchtrans obturator tapeTOTFemale Stress Urinary IncontinencecolposuspensionSUIstress urinary incontinence

Outcome Measures

Primary Outcomes (1)

  • success rate

    the absence of a subjective complaint of leakage and the absence of objective leakage during a 250-ml cough stress test

    at 1, 3 and 6 months post operative

Secondary Outcomes (3)

  • operative time

    day 1 post operative

  • complicatio rate

    till 6 months post operative

  • hospital stay

    2 days post operative

Study Arms (2)

group A laparoscopic Burch

ACTIVE COMPARATOR

laparoscopic Burch colposuspension

Procedure: laparoscopic Burch colposuspension

group B TOT

ACTIVE COMPARATOR

Trans obturator tape

Procedure: Trans obturator tape fixation

Interventions

laparoscopic Burch colposuspension for female stress urinary incontinence

group A laparoscopic Burch

mid urethral sling for female stress urinary incontinence

group B TOT

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical Diagnosis of SUI:
  • Symptoms include leakage during activities such as coughing, sneezing, laughing, or physical exertion.
  • Documented stress urinary incontinence by physical examination and urodynamic testing.
  • Adult female patients typically aged 18 years or older.
  • Completed Non-Surgical Management:
  • Patients who have tried and failed conservative management options, such as pelvic floor exercises, behavioral therapy.
  • Willingness to Undergo Surgery

You may not qualify if:

  • virgin female
  • mixed urinary Incontinence
  • Pelvic Organ Prolapse more than the 2nd degree according to Baden and Walker classification 1992
  • Previous Anti-Incontinence Surgery
  • Neurological Conditions:
  • Patients with neurogenic bladder or other neurologic disorders affecting bladder function, such as multiple sclerosis or spinal cord injury.
  • Pregnancy
  • Presence of active urinary tract infection (UTI) or other pelvic infections at the time of evaluation
  • Patients with interstitial cystitis, bladder tumors, or urethral diverticula that could complicate surgical outcomes
  • Previous history of radiotherapy to the pelvis.
  • Contraindications to surgery such as uncorrectable coagulation disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cairo university hospitals

Giza, Giza Governorate, Egypt

Location

Theodor Bilharz Research Institute

Giza, Giza Governorate, Egypt

Location

Related Publications (3)

  • Freites J, Stewart F, Omar MI, Mashayekhi A, Agur WI. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2019 Dec 10;12(12):CD002239. doi: 10.1002/14651858.CD002239.pub4.

  • Brasoveanu S, Balulescu L, Grigoras D, Erdelean D, Olaru F, Bardan R, Balint O, Margan MM, Alexandru A, Cristiana-Smaranda I, Pirtea L. Evaluating Patient Preferences and Clinical Outcomes for Modified Laparoscopic Burch Colposuspension and Transobturator Tape Procedures in Stress Urinary Incontinence Treatment. Life (Basel). 2024 Mar 14;14(3):380. doi: 10.3390/life14030380.

  • D'Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, Hamid R, Homma Y, Marcelissen T, Rademakers K, Schizas A, Singla A, Soto I, Tse V, de Wachter S, Herschorn S; Standardisation Steering Committee ICS and the ICS Working Group on Terminology for Male Lower Urinary Tract & Pelvic Floor Symptoms and Dysfunction. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019 Feb;38(2):433-477. doi: 10.1002/nau.23897. Epub 2019 Jan 25.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hussein A Hussein, professor of urology

    professor of urology , Faculty of medicine , Cairo university

    STUDY DIRECTOR
  • Ahmed I Kamel, professor of urology

    professor of urology , Theodor Bilharz Research Institute

    STUDY CHAIR
  • Ahmed H Abo-Zamel, assistant professor of urology

    assistant professor of urology , Faculty of medicine , Cairo university

    STUDY CHAIR
  • Ahmed S Kamel, lecturer of urology

    lecturer of urology , Faculty of medicine , Cairo university

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Urology specialist

Study Record Dates

First Submitted

February 2, 2026

First Posted

February 9, 2026

Study Start

May 1, 2025

Primary Completion

January 2, 2026

Study Completion

March 1, 2026

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
all the IPD will be available from date of publication and for 6 months
Access Criteria
All urologists and gynecologists interested in stress incontinence via the contact information of the principle investigator

Locations